Treatment options in subfoveal choroidal neovascularization secondary to age-related macular degeneration

Fumio Shiraga, Ippei Takasu, Chieko Shiragami

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Laser of the entire area of the neovascular lesion is the only proven treatment for subfoveal choroidal neovascularization secondary to age- related macular degeneration with a poor natural history. However, there are some limiting factors such as patient eligibility, a significant decline in visual acuity after treatment, and a very low possibility of a final vision of 20/100 or better. Although no large benefit of other treatment modalities, such as indocyanine green videoangiography-guided laser photocoagulation, surgical removal of neovascular membranes, and radiation therapy, has yet been proven, carefully selected patients may be suitable candidates for such treatments. This article reviews the status of treatment modalities for subfoveal choroidal neovascularization secondary to age-related macular degeneration, including laser photocoagulation of the entire area of the neovascular lesion, and discusses factors prognostic of visual outcome in these treatment options.

Original languageEnglish
Pages (from-to)31-39
Number of pages9
JournalSeminars in Ophthalmology
Volume13
Issue number1
Publication statusPublished - 1998

Fingerprint

Choroidal Neovascularization
Macular Degeneration
Lasers
Light Coagulation
Therapeutics
Indocyanine Green
Natural History
Visual Acuity
Radiotherapy
Membranes

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Treatment options in subfoveal choroidal neovascularization secondary to age-related macular degeneration. / Shiraga, Fumio; Takasu, Ippei; Shiragami, Chieko.

In: Seminars in Ophthalmology, Vol. 13, No. 1, 1998, p. 31-39.

Research output: Contribution to journalArticle

@article{4d07d2ae08124cb98ec128dec60f29e9,
title = "Treatment options in subfoveal choroidal neovascularization secondary to age-related macular degeneration",
abstract = "Laser of the entire area of the neovascular lesion is the only proven treatment for subfoveal choroidal neovascularization secondary to age- related macular degeneration with a poor natural history. However, there are some limiting factors such as patient eligibility, a significant decline in visual acuity after treatment, and a very low possibility of a final vision of 20/100 or better. Although no large benefit of other treatment modalities, such as indocyanine green videoangiography-guided laser photocoagulation, surgical removal of neovascular membranes, and radiation therapy, has yet been proven, carefully selected patients may be suitable candidates for such treatments. This article reviews the status of treatment modalities for subfoveal choroidal neovascularization secondary to age-related macular degeneration, including laser photocoagulation of the entire area of the neovascular lesion, and discusses factors prognostic of visual outcome in these treatment options.",
author = "Fumio Shiraga and Ippei Takasu and Chieko Shiragami",
year = "1998",
language = "English",
volume = "13",
pages = "31--39",
journal = "Seminars in Ophthalmology",
issn = "0882-0538",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Treatment options in subfoveal choroidal neovascularization secondary to age-related macular degeneration

AU - Shiraga, Fumio

AU - Takasu, Ippei

AU - Shiragami, Chieko

PY - 1998

Y1 - 1998

N2 - Laser of the entire area of the neovascular lesion is the only proven treatment for subfoveal choroidal neovascularization secondary to age- related macular degeneration with a poor natural history. However, there are some limiting factors such as patient eligibility, a significant decline in visual acuity after treatment, and a very low possibility of a final vision of 20/100 or better. Although no large benefit of other treatment modalities, such as indocyanine green videoangiography-guided laser photocoagulation, surgical removal of neovascular membranes, and radiation therapy, has yet been proven, carefully selected patients may be suitable candidates for such treatments. This article reviews the status of treatment modalities for subfoveal choroidal neovascularization secondary to age-related macular degeneration, including laser photocoagulation of the entire area of the neovascular lesion, and discusses factors prognostic of visual outcome in these treatment options.

AB - Laser of the entire area of the neovascular lesion is the only proven treatment for subfoveal choroidal neovascularization secondary to age- related macular degeneration with a poor natural history. However, there are some limiting factors such as patient eligibility, a significant decline in visual acuity after treatment, and a very low possibility of a final vision of 20/100 or better. Although no large benefit of other treatment modalities, such as indocyanine green videoangiography-guided laser photocoagulation, surgical removal of neovascular membranes, and radiation therapy, has yet been proven, carefully selected patients may be suitable candidates for such treatments. This article reviews the status of treatment modalities for subfoveal choroidal neovascularization secondary to age-related macular degeneration, including laser photocoagulation of the entire area of the neovascular lesion, and discusses factors prognostic of visual outcome in these treatment options.

UR - http://www.scopus.com/inward/record.url?scp=0031940116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031940116&partnerID=8YFLogxK

M3 - Article

C2 - 9567010

AN - SCOPUS:0031940116

VL - 13

SP - 31

EP - 39

JO - Seminars in Ophthalmology

JF - Seminars in Ophthalmology

SN - 0882-0538

IS - 1

ER -